78
Views
37
CrossRef citations to date
0
Altmetric
Review

Relaxin as a natural agent for vascular health

Pages 515-524 | Published online: 06 Jun 2008

References

  • AmbroseJABaruaRSThe pathophysiology of cigarette smoking and cardiovascular diseaseJ Am Coll Cardiol2004431731715145091
  • BaniDBigazziMMasiniERelaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit plateletsLab Invest199573709167474945
  • BaniDRelaxin, a pleiotropic hormoneGen Pharmacol19972813229112071
  • BaniDBallatiLMasiniERelaxin counteracts asthma-like reaction induced by inhaled antigen in sensitized guinea pigsEndocrinology19971381909159112386
  • BaniDFailliPBelloMGRelaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in cultureHypertension1998a31124079622136
  • BaniDMasiniEBelloMGRelaxin protects against myocardial injury caused by ischemia and reperfusion in rat heartAm J Pathol1998b1521367769588905
  • BaniDNistriSQuattroneSThe vasorelaxant hormone relaxin induces changes in liver sinusoid microcirculation: a morphologic study in the ratJ Endocrinol2001171541911739020
  • BaniDBigazziMClinical aspects and therapeutic perspectives of relaxinCurr Med Chem – Immunology, Endocrine and Metabolic Agents (CMC-IEMA)2005540310
  • BaniDNistriSBani SacchiTBasic progress and future therapeutic perspectives of relaxin in ischemic heart diseaseAnn N Y Acad Sci200510414233015956740
  • BaniDNistriSCinciLA novel, simple bioactivity assay for relaxin based on inhibition of platelet aggregationRegul Peptides2007in press
  • BaniGBani SacchiTBigazziMEffects of relaxin on the microvasculature of mouse mammary glandHistol Histopath1988333743
  • BaniGMauriziMBigazziMEffects of relaxin on the endometrial stroma. Studies in miceBiol Reprod199553253627492676
  • Bani SacchiTBigazziMBaniDRelaxin-induced increased coronary flow through stimulation of nitric oxide productionBrit J Pharmacol19951161589948564223
  • BaruaRSAmbroseJAEales-ReynoldsLJDysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatationCirculation200110419051011602492
  • BaruaRSAmbroseJASahaDCSmoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstrationCirculation2002106905812186791
  • BathgateRASamuelCSBurazinTCRelaxin: new peptides receptors and novel actionsTrends Endocrinol Metab2003142071312826326
  • BathgateRAIvellRSanbornBMInternational Union of Pharmacology LVII: Recommendations for the nomenclature of receptors for relaxin family peptidesPharmacol Rev20065873116507880
  • BigazziMDel MeseAPetrucciFThe local administration of relaxin induces changes in the microcirculation of the rat mesocaecumActa Endocrinol198611229693739555
  • BoehnertMUHilbigHArmbrusterFPRelaxin as an additional protective substance in preserving and reperfusion solution for liver transplantation shown in a model of isolated perfused rat liverAnn N Y Acad Sci200510414344015956742
  • BonnarJCoagulation effects of oral contraceptionAm J Obstet Gynecol1987157104282960241
  • CastenGGBoucekRJUse of relaxin in the treatment of sclerodermaJAMA195816631924
  • CastenGGGilmoreHRHoughtonFEA new approach to the management of obliterative peripheral arterial diseaseAngiology1960114081413691417
  • ConradKPGandleyREOgawaTEndothelin mediates renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious ratsAm J Physiol Renal Physiol1999276F76776
  • ConradKPNovakJEmerging role of relaxin in renal and cardiovascular functionAm J Physiol Regul Integr Comp Physiol200428725061
  • Cosen-BinkerLIBinkerMGCosenRRelaxin prevents the development of severe acute pancreatitisWorld J Gastroenterol20061215586816570348
  • Dallenbach-HellwegGDawsonABHisawFLThe effect of relaxin on the endometrium of monkeys-histological and histochemical studiesAm J Anat19661196178
  • DanielsonLASherwoodODConradKPRelaxin is a potent renal vasodilator in conscious ratsJ Clin Invest19991035253310021461
  • DanielsonLAKercherLJConradKPImpact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious ratsAm J Physiol Regul Integr Comp Physiol2000279R129830411003996
  • DavisonJMHomuthVJeyabalanANew aspects in the pathophysiology of preeclampsiaJ Am Soc Nephrol2004152440815339993
  • DschietzigTRitcherCBartschCThe pregnancy hormone relaxin is a player in human heart failureFASEB J200116521879511641245
  • DschietzigTBartschCStanglVIdentification of the pregnancy hormone relaxin as glucocorticoid receptor agonistFASEB J2004131536815289446
  • DschietzigTBartschCBaumannGRelaxin – a pleiotropic hormone and its emerging role for experimental and clinical therapeuticsPharm Ther20061123856
  • EddieLWBellRJLesterARadioimmunoassay of relaxin in pregnancy with an analogue of human relaxinLancet19868494134462872469
  • FailliPNistriSQuattroneSRelaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cellsFASEB J200116252411744624
  • FevoldHLHisawFLMeyerRKThe relaxative hormone of the corpus luteum. Its purification and concentrationJ Am Chem Soc19305233408
  • FormigliLPernaAMMeacciEParacrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelingJ Cell Mol Med2007111101417979885
  • FortePKnealeBJMilneEEvidence for a difference in nitric oxide biosynthesis between healthy women and menHypertension19983273049774371
  • GarberSLMirochnikYBrecklinCSRelaxin decreases renal interstitial fibrosis and slows progression of renal diseaseKidney Int2001598768211231342
  • GarberSLMirochnikYBrecklinCEffect of relaxin in two models of renal mass reductionAm J Nephrol20032381212373075
  • GrimmSBaeuerlePAReview article: the inducible transcription factor NF–κB: structure-function relationship of its protein subunitsBiochem J19932902973088452515
  • GrodsteinFStampferMJMansonJEPostmenopausal estrogen and progestin use and the risk of cardiovascular diseaseN Engl J Med1996335453618672166
  • HayashiSYamadaKEsakiTestrogen increases endothelial nitric oxide by a receptor-mediated systemBiochim Biophys Res Commun199521484755
  • HerringtonDMReboussinDMBrosnihanKBEffects of estrogen replacement on the progression of coronary-artery atherosclerosisN Engl J Med2000343522910954759
  • HisawFLExperimental relaxation of the pubic ligament of the guinea pigProc Soc Exp Biol Med1926236613
  • HisawFLHisawFLJrDawsonABEffect of relaxin on the endothelium of endometrial blood vessels in monkey (Macaca mulatta)Endocrinology196781375854952013
  • HsuSYNakabayashiKNishiSActivation of orphan receptors by the hormone relaxinScience2002295671411809971
  • HuFBStampferMJMansonJETrends in the incidence of coronary heart disease and changes in diet and lifestyle in womenN Engl J Med2000343530710954760
  • HudsonPJohnMCrawfordRRelaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clonesEMBO J19843233396548702
  • HulleySGradyDBushTRandomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research GroupJAMA1998280605139718051
  • IgarashiJMichelTSphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathwaysJ Biol Chem200127636281811470796
  • IgnarroLJSignal transduction mechanisms involving nitric oxideBiochem Pharmacol199141485901847633
  • JonasMAOatesJAOckeneJKStatement on smoking and cardiovascular disease for health care professionals. American Heart AssociationCirculation199286166491423984
  • KalinkaJHankeWSobalaWImpact of prenatal tobacco smoke exposure, as measured by midgestation serum cotinine levels, on fetal biometry and umbilical flow velocity waveformsAm J Perinatol20052241715668843
  • KhalilRASex hormones as potential modulators of vascular function in hypertensionHypertension2005462495415983238
  • Khan-DawoodFSGoldsmithLTWeissGHuman corpus luteum secretion of relaxin oxytocin and progesteroneJ Clin Endocrinol Metab198968627312918060
  • KimNYPaeHOKimYCPentoxifylline potentiates nitric oxide production in interleukin-1beta-stimulated vascular smooth muscle cells through cyclic AMP-dependent protein kinase A pathwayGen Pharmacol2002352051111827727
  • KohsakaTMinGLukasGIdentification of specific relaxin-binding cells in the human femaleBiol Reprod19985999199746753
  • KubesPSuzukiMGrangerDNNitric oxide: an endogenous modulator of leukocyte adhesionProc Natl Acad Sci USA199188465151675786
  • LeferAMTsaoPSLeferDJRole of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemiaFASEB J199152029342010056
  • LewisMDeshpandeUGuzmanLTregearGWIvellRBathgateRAWadeDJSystemic relaxin administration stimulates angiogenic cytokine expression and vessel formation in a rat myocardial infarct modelDordrecht2001Relaxin 2001: Proceedings of the 3rd international conference on relaxin and related peptidesThe Netherlands: Kluwer15967
  • LiuJConklinBRBlinNIdentification of a receptor/G-protein contact site critical for signaling specificity and G-protein activationProc Natl Acad Sci USA1995921164268524820
  • LiuCChenJSuttonSIdentification of relaxin-3/INSL7 as a ligand for GPCR142J Biol Chem2003a278507657014522967
  • LiuCEristeESuttonSIdentification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135J Biol Chem2003b278507546414522968
  • LiuCKueiCSuttonSINSL5 is a high affinity specific agonist for GPCR142 (GPR100)J Biol Chem200528029230015525639
  • MansonJEHsiaJJohnsonKCWomen’s Health Initiative InvestigatorsEstrogen plus progestin and the risk of coronary heart diseaseN Engl J Med20033495233412904517
  • MasiniEBaniDBelloMGRelaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxideEndocrinology19971384713209348198
  • MasiniENistriSVannacciARelaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathwayEndocrinology200414511061214630720
  • MasiniECuzzocreaSMazzonEProtective effects of relaxin in ischemia/reperfusion-induced intestinal injury due to splanchnic artery occlusionBrit J Pharmacol200614811243216847443
  • McDonaldGASarkarPRennkeHRelaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivoAm J Physiol Renal Physiol2003285F59F6712820641
  • MendelsohnMEKarasRHMolecular and cellular basis of cardiovascular gender differencesScience20053081583715947175
  • MensahGAHealthy endothelium: the scientific basis for cardiovascular health promotion and chronic disease preventionVasc Pharmacol2007463104
  • MinGSherwoodODIdentification of specific relaxin-binding sites in the cervix mammary glands nipples, small intestine and skin of pregnant pigsBiol Reprod1996551243528949880
  • MoncadaSPalmerRMJHiggsEANitric oxide physiology pathophysiology, and pharmacologyPharmacol Rev199143109421852778
  • NapoliCde NigrisFWilliams-IgnarroSNitric oxide and atherosclerosis: an updateNitric Oxide2006152657916684613
  • NathanCNitric oxide as a secretory product of mammalian cellsFASEB J199263051641381691
  • NedeljkovicZSGokceNLoscalzoJMechanisms of oxidative stress and vascular dysfunctionPostgrad Med, J200379195912743334
  • NistriSBaniDRelaxin receptors and nitric oxide synthases. Search for the missing linkReprod Biol Endocrinol20031512646076
  • NistriSChiappiniLSassoliCRelaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanismFASEB J20031721091114500542
  • NistriSBigazziMBaniDRelaxin as a cardiovascular hormone. Physiology, pathophysiology and therapeutic promisesCardiovasc Hematol Agents Med Chem (CHA-MC)200751018
  • NovakJDanielsonLAKerchnerLJRelaxin is essential for renal vasodilation during pregnancy in conscious ratsJ Clin Invest200110714697511390429
  • O’ByrneEMCarriereBTSorensenLPlasma immunoreactive relaxin levels in pregnant and nonpregnant womenJ Clin Endocrinol Metab197847110610263340
  • OrshalJMKhalilRAGender, sex hormones and vascular toneAm J Physiol Regul Integr Comp Physiol2004286R2334914707008
  • OstoECoppolinoGVolpeMRestoring the dysfunctional endotheliumCurr Pharm Des20071310536817430168
  • PalmerRMJFerrigeAMoncadaSNitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature198732752463495737
  • PernaAMMasiniENistriSNovel drug development opportunity for relaxin in acute myocardial infarction. evidences from a swine modelFASEB J2005191525716009702
  • PriceJFMowbrayPILeeAJRelationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery StudyEur Heart J1999203445310206381
  • QuattroneSChiappiniLScapagniniGRelaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro cultureMol Hum Reprod2004103253015026539
  • RadomskiMVPalmerRMJMoncadaSThe role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumBiochem Biophys Res Commun1987148148292825688
  • RosanoGMVitaleCFiniMhormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?Ann N Y Acad Sci20061092341817308159
  • SaderMACelermajerDSEndothelial function, vascular reactivity and gender differences in the cardiovascular systemCardiovasc Res5359760411861030
  • SamuelCSUnemoriENMookerjeeIRelaxin modulates cardiac fibroblast proliferation differentiation and collagen production and reverses cardiac fibrosis in vivoEndocrinology200314541253315155573
  • SamuelCSDuXJBathgateRADRelaxin’ the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular diseasePharm Ther200611252952
  • SchwabeCBüllesbachEERelaxin: structure, functions, promises and nonevolutionFASEB J199481152607958621
  • SherwoodODRelaxin’s physiological roles and other diverse actionsEndocr Rev2004252053415082520
  • SiowRCMLiFYLRowlandsDJCardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genesFree Rad Bio Med2007429092517349919
  • SluiterWPietersmaALamersJMJLeukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanism underlying their expressionJ Cardiovasc Pharmacol199322Suppl 4S37447523771
  • SmithGCPellJPWalshDPregnancy complications and maternal risk of ischaemic heart disease: A retrospective cohort study of 129,290 birthsLancet20013572002611438131
  • StewartDRCelnikerACTaylorCAJrRelaxin in the peri-implantation periodJ Clin Endocrinol Metab199070177132347909
  • St-LouisJMassicotteGChronic decrease of blood pressure by rat relaxin in spontaneously hypertensive ratsLife Sci198537135174046737
  • SudoSKumagaiJNishiSH3 Relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2J Biol Chem200327878556212506116
  • TaylorMJClarkCLEvidence for a novel source of relaxin: atrial cardiocytesJ Endocrinol1994143R587829984
  • TunstallPHKuulasmaaKPAmouyelPMyocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures event rates and case-fatality rates in 38 populations from 21 countries in four continentsCirculation1994905836128026046
  • UnemoriENAmentoEPRelaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblastsJ Biol Chem19902651068152162358
  • UnemoriENBauerEAAmentoEPRelaxin alone and in conjunction with interferon-γ decreases collagen synthesis by cultured human scleroderma fibroblastsJ Invest Dermatol199299337421512471
  • UnemoriENBeckLSLeeWPHuman relaxin decreases collagen accumulation in vivo in two rodent models of fibrosisJ Invest Dermatol199310128058370965
  • UnemoriENPickfordLBSallesALRelaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivoJ Clin Invest1996982739458981919
  • UnemoriENEriksonMERoccoSERelaxin stimulates expression on vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in womenHum Reprod199914800610221717
  • VanhouttePMEndothelial dysfunction and atherosclerosisEur Heart J199718E19299402468
  • VasilenkoPMeadJPWeidmannJEUterine growth-promoting effects of relaxin: A morphometric and histological analysisBiol Reprod198635987953814710
  • WeiJYAge and the cardiovascular systemN Engl J Med1992327173591304738
  • WengerNKSperoffLPackardBCardiovascular health and disease in womenN Engl J Med1993329247568316269
  • WilliamsEJBenyonRCTrimNRelaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivoGut2001495778311559657
  • WilsonBCConnellBSalehTMRelaxin-induced reduction of infarct size in male rats receiving MCAO is dependent on nitric oxide synthesis and not estrogenic mechanismsNeurosci Lett2006393160416233954
  • WinslowJWShihABourellJHHuman seminal relaxin is a product of the same gene as human luteal relaxinEndocrinology19921302660881572287
  • WyckoffMHChamblissKLMineoCPlasma membrane estrogen receptors are coupled to endothelial nitric oxide synthase through Gαi J Biol Chem200127627071611369763
  • ZdravkovicTGenbacevOMcMasterMTThe adverse effects of maternal smoking on the human placenta: a reviewPlacenta200526Suppl AS81615837073
  • ZhangJQiYFGengBEffect of relaxin on myocardial ischemia injury induced by isoproterenolPeptides2005261632916112403
  • ZicheMMorbidelliLMasiniENitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance PJ Clin Invest1994942036447525653